Cargando…
Delayed presentation of late-onset cerebrospinal fluid rhinorrhoea following dopamine agonist therapy for giant prolactinoma
Therapeutic shrinkage of prolactinomas with dopamine agonists achieves clinical benefit but can expose fistulae that have arisen as a result of bony erosion of the sella floor and anterior skull base by the invasive tumour, resulting in the potential development of cerebrospinal fluid (CSF) rhinorrh...
Autores principales: | Prague, J K, Ward, C L, Mustafa, O G, Whitelaw, B C, King, A, Thomas, N W, Gilbert, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235146/ https://www.ncbi.nlm.nih.gov/pubmed/25520847 http://dx.doi.org/10.1530/EDM-14-0020 |
Ejemplares similares
-
Late presentation of acromegaly in medically controlled prolactinoma
patients
por: Manuylova, Ekaterina, et al.
Publicado: (2016) -
Reversal of severe cognitive impairment following medical treatment of cystic invasive giant prolactinoma
por: Bukowczan, J, et al.
Publicado: (2016) -
Foster Kennedy syndrome secondary to a giant prolactinoma with a remarkable response to cabergoline
por: Kanj, Usama, et al.
Publicado: (2022) -
A case of ectopic ACTH syndrome treated with intermittent administration of dopamine agonists
por: Sakihara, Satoru, et al.
Publicado: (2014) -
A ‘giant’ paraganglioma in the testis
por: Makris, Marinos C, et al.
Publicado: (2014)